A phase II study of G17DT in gastric carcinoma
Authors:
- S.A WatsonSWS.A Watson
- 1 June 2004
- journal article
- clinical trial
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 30 (5) , 536-543
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A Systematic Overview of Chemotherapy Effects in Gastric CancerActa Oncologica, 2001
- A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancerEuropean Journal of Surgical Oncology, 2000
- Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): Improved treatment for gastric adenocarcinomaSurgery, 2000
- Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282Medical Oncology, 1999
- Estimates of the worldwide mortality from 25 cancers in 1990International Journal of Cancer, 1999
- Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples: Where are they really located?International Journal of Cancer, 1999
- Differential expression of the CCK-A and CCK-B/gastrin receptor genes in human cancers of the esophagus, stomach and colonInternational Journal of Cancer, 1997
- Evaluation of cholecystokinin, gastrin, CCK-A receptor, and CCK-B/gastrin receptor gene expressions in gastric cancerCancer Letters, 1996
- Adenocarcinoma of the stomach: are we making progress?The Lancet, 1993
- Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitroBritish Journal of Surgery, 1988